Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2014

HLA-DRB1-Associated Rheumatoid Arthritis Risk
at Multiple Levels in African Americans
Hierarchical Classification Systems, Amino Acid
Positions, and Residues
R. J. Reynolds
A. F. Ahmed
M. I. Danila
L. B. Hughes
P. K. Gregersen
Zucker School of Medicine at Hofstra/Northwell
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Internal Medicine Commons
Recommended Citation
Reynolds R, Ahmed A, Danila M, Hughes L, Gregersen P, Raychaudhuri S, Plenge R, Bridges S, Consortium Longitudinal Evaluat A.
HLA-DRB1-Associated Rheumatoid Arthritis Risk at Multiple Levels in African Americans Hierarchical Classification Systems,
Amino Acid Positions, and Residues. . 2014 Jan 01; 66(12):Article 2329 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/2329. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

R. J. Reynolds, A. F. Ahmed, M. I. Danila, L. B. Hughes, P. K. Gregersen, S. Raychaudhuri, R. M. Plenge, S. L.
Bridges, and Af Consortium Longitudinal Evaluat

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/2329

NIH Public Access
Author Manuscript
Arthritis Rheumatol. Author manuscript; available in PMC 2015 December 01.

NIH-PA Author Manuscript

Published in final edited form as:
Arthritis Rheumatol. 2014 December ; 66(12): 3274–3282. doi:10.1002/art.38855.

HLA-DRB1 rheumatoid arthritis risk in African Americans at
multiple levels: Hierarchical classification systems, amino acid
positions and residues
Richard J. Reynolds1,*, Altan F. Ahmed1,*, Maria I. Danila1, Laura B. Hughes1, CLEAR
Investigators2, Peter K. Gregersen3, Soumya Raychaudhuri4, Robert M. Plenge5, and S.
Louis Bridges Jr1
1University

of Alabama at Birmingham

2Richard

NIH-PA Author Manuscript

D. Brasington, Jr. MD (Washington University at St. Louis), Leigh F. Callahan, PhD
(University of North Carolina at Chapel Hill), Doyt L. Conn, MD (Emory University), Beth L. Jonas,
MD (University of North Carolina at Chapel Hill), Larry W. Moreland, MD (University of
Pittsburgh), Edwin A. Smith, MD (Medical University of South Carolina)
3Feinstein

Institute for Medical Research, Manhasset, NY.

4Brigham

& Women's Hospital, Harvard Medical School, Division of Genetics & Rheumatology,
Boston, MA.

5Merck

& Co., Inc.

Abstract
Objective—To evaluate African American rheumatoid arthritis HLA-DRB1 genetic risk by three
validated allele classification systems, and by amino acid position and residue. To compare the
genetic risk between African American and European ancestries.
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Methods—Four-digit HLA-DRB1 genotyping was performed on 561 autoantibody-positive
African American cases and 776 African American controls. Association analysis was performed
on Tezenas du Montcel (TdM); de Vries (DV); and Mattey classification system alleles and
separately by amino acid position and individual residues.
Results—TdM S2 and S3P alleles were associated with RA (odds ratios (95% CI) 2.8 (2.0, 3.9)
and 2.1 (1.7, 2.7), respectively). The DV (P-value=3.2 x 10−12) and Mattey (P-value=6.5 x 10−13)
system alleles were both protective in African Americans. Amino acid position 11 (permutation Pvalue < 0.00001) accounted for nearly all variability explained by HLA-DRB1, although
conditional analysis demonstrated that position 57 was also significant (0.01<= permutation P-val
<=0.05). The valine and aspartic acid residues at position 11 conferred the highest risk for RA in
African Americans.
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Conclusion—With some exceptions, the genetic risk conferred by HLA-DRB1 in African
Americans is similar to European ancestry at multiple levels: classification system (e.g., TdM),
amino acid position (e.g. 11) and residue (Val 11). Unlike that reported from European ancestry,
amino acid position 57 was associated with RA in African Americans, but positions 71 and 74
were not. Asp11 (OR = 1 in European ancestry) corresponds to the four digit classical allele,
*09:01, also a risk allele for RA in Koreans.
The largest contributor of RA genetic risk in the major histocompatibility complex (MHC) is
HLA-DRB1. Stastny (1) first reported an association between the HLA-DRw4
(HLADRB1*04) alloantigen and RA. The DRw4 alloantigen was found in 70% of
rheumatoid factor positive RA patients as compared to 28% of the healthy controls.
Gregersen et al. (2) observed that genetic variation among DR4 haplotypes is restricted to
the HLA-DRB1 gene. This variability is restricted to the codons surrounding amino acid
position 70 in the third hypervariable region of HLA-DRB1. Gregersen et al. also noted a
region of conserved amino acids from position 70-74 in the DRB1*04 and DRB1*01 alleles
associated with RA. This region of conservation was named the shared epitope (SE). Despite
validation of the SE hypothesis, the exact mechanism by which the SE contributes to RA
remains unknown.
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Recent research demonstrates that the majority of the known genetic risk for autoantibody
positive rheumatoid arthritis (RA) arises from allelic variants of two class II (HLADRB1 and
HLA-DPB1) and one class I (HLA-B) MHC genes (3, 4). HLA-DRB1 in particular has
consistently been shown to be highly associated with RA across ethnicities (3, 5, 6). Certain
amino acid residues at positions 11, 71, and 74 account for the majority of the association of
HLA-DRB1 with RA risk (3). The residues corresponding to the traditional SE (positions 71
and 74) and the newly defined risk residue (valine11) are all located in the peptide binding
groove of the HLA-DRB1 molecule. Therefore, the variable risk conferred by HLA-DRB1
appears to be explained by specific amino-acid substitutions in the primary structure of its
polypeptide chain.
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The original description of the SE hypothesis did not address the potential variation in risk
among the different SE containing alleles. Subsequent detailed studies in European ancestry
populations have shown that there exists a hierarchy of risk among SE alleles (7-10).
Tezenas du Montcel et al. (9) proposed an alternative classification system to overcome
these limitations. In this system, SE-containing HLA-DRB1 alleles are further categorized
into genotypes based on the amino acids at positions 70 and 71. These amino acids appear to
modify the genotypic risk conferred by the conserved motif at positions 72-74. For example,
the genotypic risk of KRAA - Q/R RRAA heterozygotes was found to be higher than the
homozygotes for each motif. Specifically, genotypes with one allele that differ by a
substitution of arginine for lysine at position 71 and the presence of a glutamine or arginine
at position 70 appear to have the highest risk for RA. However, the study by Morgan et al.
(11) demonstrated that the highest risk genotype was characterized by the presence of the
KRAA sequence on both alleles. In addition, de Vries et al. (10) and Mattey et al. (12) have
observed that isoleucine and aspartic acid amino acid substitutions at positions 67 and 70,
respectively, are less common in cases than in controls of European ancestry. The TdM, DV
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and Mattey systems of HLA-DRB1 reclassification have all been validated in people of
European ancestry (9, 10, 12), but have not been examined in African Americans.
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Populations of various ethnicities differ in terms of variability of linkage disequilibrium,
haplotype structure and allele frequency differentiation, which may result from neutral or
selective evolutionary forces (13, 14). Therefore, the genetic risk of reclassified HLA-DRB1
alleles, e.g. TdM system or the risk evident at amino acid positions or specific residues, may
vary among different ancestries. Hughes et al. (5) addressed the hypothesis that African
Americans’ genetic risk for RA through the HLA-DRB1 SE is indirect (as a marker of
increased European genetic admixture); support for this was modest compared to similar
studies in systemic lupus erythematosus (15). Nevertheless, this raises the possibility that the
specific HLA-DRB1 alleles responsible for disease risk may differ in African and European
ancestral populations. Compared to peoples of European descent, African Americans are
thought to have a lower prevalence of RA (16), lower frequency of the highest risk HLADRB1 classical alleles (e.g. *04:01, *04:04), and lower effect size of the high risk alleles
with RA (5). However, the well-established hierarchy of risk conferred by SE-containing
alleles has not been previously investigated in the African American RA population, nor has
the risk been quantified at the amino acid position or residue levels.

NIH-PA Author Manuscript

In this study we sought to evaluate the applicability of the TdM, DV, and Mattey systems of
HLA-DRB1 alleles and to define genetic risk at individual amino acids across HLA-DRB1
exon 2 in a large sample of autoantibody positive African American RA patients and healthy
controls. The specific objectives of this analysis were to test the following hypotheses: 1) the
TdM system allele risk hierarchy correlates with RA in African Americans; 2) the DV and
Mattey-classified risk alleles, shown to be “protective” in peoples of European ancestry, i.e.
higher frequencies in controls than cases, are also protective in African Americans; 3) the
highest risk alleles in African-Americans contain a valine residue at position 11 (V11); and
4) the RA risk conferred by HLA-DRB1 alleles at all levels of analysis is similar between
African Americans and Europeans.
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This study provides novel insight into the association of specific amino acid motifs with RA
in African Americans in light of the newly defined high risk V11 variant of HLA-DRB1 in
exon 2. We also make conclusions, supported by strong empirical evidence, concerning the
level of trans-ethnic variation in the risk conferred by the four classifications of HLA-DRB1
alleles.

PATIENTS AND METHODS
Study patients and controls
We analyzed HLA-DRB1 genotype data of 561 African American autoantibody positive RA
patients and 776 healthy African American controls. All patients with RA were participants
in the Consortium for the Longitudinal Evaluation of African Americans with Early
Rheumatoid Arthritis (CLEAR) Registry previously described by our group (5, 16). The
healthy African American controls were age-, sex-, and geographic location-matched to the
CLEAR RA patients. 358 of the 776 healthy African American controls were from the
CLEAR registry; the remaining 418 controls were recruited from the Birmingham, Alabama
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area. All protocols were approved by the University of Alabama at Birmingham Institutional
Review Board for Human Use.
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Sequencing and genotyping
High resolution DRB1 sequencing was completed for all study participants using the
AlleleSEQR HLA DRB1 reagent kit and protocol (Abbot) and the ABI 377 automated
sequencer (Applied Biosystems, Foster City, CA). Four digit DRB1 genotypes were
assigned using Assign software (Conexio Genomics, Fremantle, Western Australia,
Australia).
Statistical analysis
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In order to test the hypothesis that the TdM classification system allele risk hierarchy
correlates with RA in African Americans, we first defined S2, S3P and L alleles based on
the classical allele amino acid sequence from position 70-74 (Table 1). We then estimated
genome-wide ancestry using the software Admixture (17), using a set of ~30,000 autosomal
and genome-wide SNP markers with partial correlation < 0.5 (i.e. approximate linkage
equilibrium), and minor allele frequency greater than 0.05 typed on the Illumina
ImmunoChip array (18). The Immunochip marker set matched 21,106 markers from
HAPMAP representing the 2 founding populations (CEU and YRI). In order to obtain
markers informative for ancestry in the admixed sample, only markers (N =3,826) with
different minor alleles between the two ancestral populations were extracted from the 21,106
SNP set. The average difference in MAF between the two ancestral populations for these
3,826 markers was 0.35, which is sufficiently informative for admixture estimation for
models assuming two founding populations (19). Admixture models were fit with and
without individuals from HAPMAP known to be 100% European (N = 3) and 100% African
(N = 3). Estimated proportion ancestry for these individuals using the genome wide panel of
3,826 markers were identical to expectations.
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We fit base models of RA case affectation status as the logit of proportional European
admixture and sex. A second model was fit that included the base model predictors and two
additional variables. These variables were numerically coded as the number of copies {0, 1,
2} of the S2 and S3P alleles (TdM classification) or N or P alleles (DV & Mattey
classifications). These models were fit using the “glm” function in R (20) assuming a
binomial response with a logit link function. ANOVA was used to test the hypothesis of RA
association with number of copies of TdM classification, DV and Mattey system alleles by
comparing the change in model deviance between the models with and without the genetic
variables. The P-values of the test that the model with the genetic variables was a better fit
to the case affectation data than the base model were calculated assuming the test statistic
was distributed as χ2(2).
Genotypic association analysis was performed by fitting a base model of case affectation
status as the logit of European admixture proportion and sex, and then a second model,
identical with the base except for the addition of a third variable coding the six TdM
classification system genotypes; e.g., S2/L, S3P/L, S2/S2, etc. The L/L genotype was the
referent. To test the hypothesis that the TdM classification system genotypes were
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associated with case affectation status, like the allelic association models described above,
ANOVA was used to compare the two nested models, one with and one without the
genotype variable. The test statistic is the change in the model deviance which is
asymptotically distributed as χ2(5).
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We tested the hypothesis that the newly discovered valine motif at HLA-DRB1 amino acid
position 11 shown to be associated with RA among European ancestry also is a risk factor
among African Americans. To test this hypothesis we created new variables corresponding
to the presence or absence of residues at each relevant amino acid position across HLA
DRB1 exon 2. Each amino acid position contains a variable number (= p) of residue
substitutions. For example position 11 contains six residues. We evaluated the association of
each position (containing p residues) by fitting two statistical models, one with and another
without the p-1 variables amino residues. The full model contained sex, proportion
European admixture and the p-1 variables corresponding to the number of copies of residues
each individual had for each amino acid. The reduced model did not contain the p-1 residue
variables. The change in residual deviance between the full and reduced models was
computed. The models were binomial regressions of case control status fit using the glm
function in R. Because all amino acid positions are physically linked, we used permutation
test p-values to determine the statistical significance of the residues comprising each amino
acid position. The permutation test was performed by permuting the unique combination
comprising the set of residues for a given position and the corresponding sex and admixture
proportion for each individual. The change in the deviance over the null model was observed
for each amino acid position, and the maximum deviance for each iteration (n = 100,000)
was selected to generate a null distribution of test statistics. In addition, we assessed the
evidence that additional positions beyond the most highly associated position contributed to
variation in case control status by conditioning out its variability and testing the effect of
each additional position again using binomial regression analysis. We also used permutation
test p-values to assess statistical significance of the conditional tests. We compared risk
profiles between European and African American ancestries by comparing univariate odds
ratios of the residues within the most highly associated amino acid positions estimated in the
present study with estimates from European populations reported in the literature (9) (11).
With 30 amino acids tested we consider results highly significant at the Bonferroni corrected
alpha level = 0.0017.
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RESULTS
Of the 561 participants, 465 (83%) were women, with mean (± SD) age 46 ± 13 years; 303
(54%) had ever smoked and 241 (43%) had at least one shared epitope (SE) allele. The mean
disease duration (± SD) of RA was 7.3 ± 9 years. The base model contained a statistically
significant effect of sex (p=5.6E-06) but proportion European ancestry was not significantly
associated with case-control status (p=0.11).
An allelic model that included the dosage (0, 1, or 2) of the S2 and S3P TdM classification
system alleles in addition to the covariates sex and genetic admixture proportion explained
significantly more of the variation in affectation status than the non-genetic covariates alone
(χ2 = 74.4, DF = 2, p-value = 7.0e-17). The risk hierarchy of the TdM classification system
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alleles based on magnitude of effect alone was S2 > S3P > L (Table 2). The S2 susceptibility
allele effect, adjusting for S3P had an odds ratio (95% CI) of 2.8 (2.0-3.9). The S3P allele
effect, adjusting for S2, had an odds ratio of 2.1 (1.7-2.7).
A genotypic model including a variable defining the six TdM system genotypes in addition
to the covariates also explained significantly more variation in affectation status than the
covariates alone (χ2= 77.1, DF=5, p-value = 3.4e-15). The risk hierarchy of the TdM
classification system genotypes was S2/S3P > S3P/S3P > S2/S2 > S2/L > S3P/L (Table 2).
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The allelic odds ratios of TdM classification system HLA-DRB1 RA risk alleles from
African Americans were nearly identical to the estimates in Europeans reported by Morgan
et al. (11) (Table 3, Figure 1). For both ethnicities, the frequency of S2 and S3P alleles in
RA cases was much higher than for controls. Among Europeans, the estimated odds ratio for
the S2 allele was about 50% higher than for the S3P allele; for African Americans, its
estimate was 33% higher. The highest risk genotype in African Americans was S2/S3P,
which has also been reported in some European samples (9, 21). The study by Morgan et al.
(11) reported that the highest genotypic risk in Europeans was conferred by S2/S2. The
lowest risk genotype in African Americans was S3P/L, which is also the lowest risk
genotype for Europeans. The pattern of effect sizes according to allelic and genotypic
models was remarkably similar between European and African American populations. The
greatest variability in genotypic risk between African Americans and Europeans appeared to
be for the S2 homozygotes and S2/S3P heterozygotes; the risk associated with these
genotypes is also heterogeneous among the studies of Europeans.
Based on permutation test p-values, amino acid positions (in ascending order of p-values)
11, 13, 33, 47, 10, 57, 12, 30, and 86 were significantly associated with RA (Figure 2).
When conditioning on amino acid 11, no other position was statistically significant at the
alpha = 0.001 level. Position 57 was marginally significant with permutation p-value
between 0.05 and 0.01; notably this residue resides near the peptide binding groove on the
beta subunit of HLA DR molecule.
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Certain residues of amino acid position 11 are similar in risk to that observed in Europeans,
but there are exceptions. The valine residue has the highest risk. Its OR (95% CI) is 3.0 (2.3,
4.0) with residue frequencies of 0.17/0.07 in cases/controls respectively, consistent with the
observations among Europeans (Figure 3). Aspartic acid at amino acid 11 is also a risk
residue in African Americans. The OR (95% CI) is 1.9 (1.3, 2.7) with residue frequency of
0.06/0.03 in cases and controls, respectively, but in Europeans, it is found at very low
frequency and is not associated with RA. All African Americans (N = 5) homozygous for
aspartic acid at residue 11 are homozygous for HLA-DRB1 *09:01. This classical allele has
been observed to have very low frequency in Europeans. Accordingly, HLA-DRB1 09:01
has a frequency of 0.06/0.03 in African American cases and controls, respectively with a
corresponding odds ratio (95% CL) of 1.9 (1.3, 2.7).
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The HLA-DRB1 locus is highly polymorphic, confers more risk for RA than any other locus,
and the risk varies according to specific amino acid residues in the peptide binding region of
the HLA-DRB1 molecule. Notably, the frequencies of these high risk alleles (i.e., specific
amino acid residues near position 70) are known to be different among ethnic groups. Here
we have endeavored to define the variable genetic risk within African Americans (776
healthy controls and 561 autoantibody positive cases), making this the largest study
analyzing the genetic risk conferred by HLA-DRB1 on RA in African Americans to date.
Our major finding is that HLA-DRB1 SE alleles reclassified according to amino position
confer substantial risk for RA in African Americans, whether the scale of analysis is at allele
groupings (e.g, Tezenas du Montcel) or specific amino positions (e.g, position 11) and
residues (e.g. valine 11). Furthermore, the risk observed in African Americans is remarkably
similar to findings from Europeans, no matter the scale of analysis, notwithstanding highly
variable allele frequencies between ancestries. We demonstrated that amino acid position 11
harbors the highest source of variation in RA risk in African Americans primarily from
valine and aspartic acid residues. We have also defined HLADRB1 09:01 as a novel risk
allele for African Americans with RA, similar to findings in Koreans with RA (6).
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We found that in this sample of African Americans, HLA-DRB1 risk alleles defined by the
TdM classification system were very highly associated with RA, at both the allelic and
genotypic levels, over a base model of sex and proportion European ancestry. This result
validates the applicability of the TdM hierarchical classification system in this ethnic group.
The strength of the relationship between S2 alleles and RA (OR=2.8) is 33% stronger than
for the S3P alleles (OR=2.1). The group of high risk alleles defined by S2, containing the
amino acid motif KRAA at positions 71-74 and including a lysine at position 71, carries the
highest risk. S3P alleles differ from S2 alleles in the presence of an arginine at position 71
and either an arginine or glutamine at position 70. Even between the high risk alleles, it
appears that the different hierarchical risk may be attributed to amino acid substitutions at
position 71.
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The estimated odds ratio of association for S2 and S3P alleles from the present study are
essentially identical to those estimated from the Morgan et al. (11) study (Figure 1) and
qualitatively similar to the smaller but seminal Tezenas du Montcel et al. (9) study. The
effect sizes in the present study also corroborate the findings recently reported by Mackie et
al. (n=3657) (22). Furthermore, the N and P alleles of the DV and Mattey classification
systems are protective in African Americans, a finding consistent with those of Morgan et
al. (11). Therefore, in terms of allelic association statistics, the TdM, DV and Mattey
systems of HLA-DRB1 alleles do not support the hypothesis of genetic heterogeneity in risk
profiles between ethnic groups. Furthermore, the homogeneity of allelic effects observed
across ethnic groups is also evident in genotypic effects. We found that the S2/S3P
heterozygous genotype had the highest risk followed by the S3P homozygote, then the S2
homozygote, the S2/L heterozygote and finally, the S3P/L heterozygote. We found
discordance with the Morgan study for the highest genotypic risk (S2/S2), but agreement
with the Tezenas du Montcel et al. (9) and Michou et al. (21) studies (S2/S3P). It is highly
probable that the differences observed in genotypic risk among these studies is due to
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sampling variability, due to very low expected frequencies of subjects homozygous for the
S2/S2 genotypes.
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We also categorized the classical HLA-DRB1 alleles according to the presence/absence of
amino acid residues for each position across exon 2. We report here that variability
explained by position 11 is also highly associated with RA in African Americans, identical
to the result reported in peoples of European descent (3). Unlike the result reported in
European ancestry, we were not able to demonstrate that either positions 71 and 74 were
significant according to the distribution of permutation test statistics. Lysine at position 71
and alanine at position 74, which were the high risk residue in Europeans, had odds ratios
(95% CL) of 1.2 (0.96, 1.4) and1.1 (0.96,1.4), respectively in the African American sample.
The two residues were common with the lysine 71 and alanine 74 control frequencies at 0.18
and 0.65, respectively. After accounting for variability due to position 11, there was no more
variance explained significantly by any positions, except possibly position 57. This position
is also located in the binding groove of the beta chain of HLA-DR molecule. Thus, we
conclude that the bulk of the variability of HLA-DRB1's effect on RA in this sample is
explained by substitutions of residues within position 11, which is explained primarily by
valine and aspartic acid. The aspartic acid residue is specific to the classical allele HLADRB1 *09:01, which has been shown to be a risk allele for RA in Koreans (6). Therefore we
conclude that HLA-DRB1 *09:01 is also a risk allele in African Americans.
Similar to the report by Hughes et al. (5) we did not find that genome-wide proportion
European admixture was associated with RA risk (Table 2). There remains uncertainty
regarding the conclusion that RA risk among African Americans is due to the introgression
of European derived HLA-DRB1 alleles. Global admixture is known to be a poor proxy for
local ancestry of alleles (23). Thus we acknowledge the limitation of the current study in
explicitly testing the null hypothesis that RA genetic risk is homogeneous between
ethnicities and is independent of European ancestry. It seems unlikely, however, that
ancestry explains the consistent hierarchy of risk for SE alleles among the European and
African American populations. For this to be the case, one must hypothesize that very strong
susceptibility alleles are in linkage disequilibrium with the various HLA-DRB1 risk alleles,
and this is generally not consistent with current data (3).
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In conclusion, we have validated the association of several classification systems of HLADRB1 alleles, amino acid position 11, and the specific residue valine11, with risk for RA in
African Americans. Previously our group reported that risk conferred by non-MHC alleles
tagging validated RA risk loci was also similar to populations of European descent, although
there were a few exceptions (24). Three SNPs had risk opposite to that observed among
Europeans (25), and the causal PTPN22 SNP, rs2476601, for example, was nearly
monomorphic in the African American sample. There were also differences between the
ethnic groups observed in HLA-DRB1 risk: The aspartic acid at position 11 is a risk allele
(neutral in Europeans), and the risk evident among Europeans at position 71 and 74 was not
observed in this sample of African Americans. Finally, it appeared that residue substitutions
at amino acid position 57 also are associated with RA risk independent from the effects
observed at position 11. The conclusions regarding the homogeneity of risk attributed to
large and modest effect RA risk loci and the differential allele frequencies observed between
Arthritis Rheumatol. Author manuscript; available in PMC 2015 December 01.
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ethnicities are promising in terms of potential gains in statistical power for mapping new RA
risk loci using multiethnic sample sets (26, 27). Overall, the accumulating body of evidence
demonstrates that the genetic basis of RA is highly uniform between African Americans and
Europeans, with certain exceptions, notably the novel finding that *09:01 is a RA risk allele
in the African American population. Future directions include estimating local admixture
(e.g., using the software HAPMIX (28) or LAMP-LD (29)) in the region of chromosome 6
immediately flanking HLA-DRB1 in the African American sample in order to obtain more
detailed results on HLA-DRB1 genetic risk stratified by ancestry.
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Figure 1.

TdM classified HLA DRB1 genotypic and allelic odds ratios of RA risk compared between
Europeans and African Americans. Confidence limits (Cl) along y-axis correspond to
African Americans from the CLEAR registry and CI limits along x-axis correspond to
European SE OR reported by Morgan et al. The black (white) filled circles are allelic
(genotypic) odds ratios. The 1:1 dotted line indicates equivalent odds ratios between
ethnicities. All genotypic odds ratios are significantly different from the referent genotype,
L/L, except for African American S2/S2. The inserted graph in the upper right hand
quadrant of the figure zooms in on the region defined by OR less than four.
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Figure 2.

Permutation test distribution of deviance statistics under the null hypothesis (top) that there
is no correlation between any tested amino acid position and RA and (bottom) that there is
no correlation between any tested position after accounting for the effect due to position 11.
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Figure 3.

Univariate odds ratios (95% CI) for amino acid positions 11 and 57 associated significantly
with RA in African African Americans. Bar plots show frequency of reference alleles
between cases and controls.
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HLA-DRB1 classification. Not shown are L alleles corresponding to the KRGR (71 - 74) motif (*03:01,
*03:02), and RRGQ (*07:01). Shared epitope alleles are shown in bold.
Tezenas du Montcel Allele

L

S3P

S2

Amino Acid Motif (pos 70-74)

ARAA

ERAA

DRRAA

Q/RRRAA

KRAA

HLA-DRB1 Alleles

*15:01

*01:03

*11:02

*01:01

*04:01

*15:02

*04:02

*11:03

*01:02

*13:03

*15:03

*13:01

*12:02

*04:04

*13:02

*13:05

*04:05

*16:01

*04:08
*10:01
*14:02
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Table 2

NIH-PA Author Manuscript

Model fit statistics and parameter estimates from 1) the base model of affectation status including the
intercept, sex and proportion European admixture and 2) the model including the allelic effects conferred by
*

TdM-classified HLA-DRB1 alleles . There were 561 cases and 776 controls. P-values reported are from tests
that the parameter estimates are significantly different than zero.
Frequency (cases)

Frequency (controls)

OR

CL

p-value

Base model, N = 1,337, deviance=1794.7, DF = 1,334, AIC= 1800.7
Intercept

0.92

(0.77,1.1)

0.82

Sex (Male)

0.17

0.28

0.52

(0.40,0.69)

5.6e-06

Sex (Female)

0.83

0.72

--

(--,--)

--

European admixture

--

--

0.43

(0.15,1.2)

0.11

Base + TdM alleles, deviance = 1720.3, DF = 1,332, AIC = 1730.2
S2

0.10

0.045

2.8

(2.0,3.9)

2.8e-10

S3P

0.19

0.11

2.1

(1.7,2.7)

2.2e-10

L

0.71

0.84

--

(--,--)

--

Base + TdM genotypes, deviance = 1717.6, DF = 1,329, AIC = 1733.6

NIH-PA Author Manuscript

S2/S3P

0.040

0.0064

9.3

(3.4,26)

9.0e-06

S3P/S3P

0.026

0.0090

4.9

(1.9,13)

0.00072

S2/S2

0.0052

0.0038

2.6

(0.48,14)

0.26

S2/L

0.15

0.076

2.8

(2.0,4.1)

1.8e-08

S3P/L

0.29

0.19

2.0

(1.5,2.7)

2.5e-07

L/L

0.50

0.71

REF

(--,--)

--

Base +DeVries alleles, deviance = 1734, DF=1,332, AIC = 1744.2
N

0.32

0.38

0.42

(0.33,0.54)

1.2e-12

P

0.44

0.49

0.45

(0.36,0.57)

3.2e-12

SE

0.24

0.13

REF

(--,--)

--

Base +Mattey alleles, deviance = 1735, DF=1,332, AIC = 1744.8
N

0.30

0.34

0.44

(0.35,0.57)

2.7e-11

P

0.46

0.53

0.44

(0.35,0.55)

6.5e-13

SE

0.24

0.13

REF

(--,-- )

--

*

NIH-PA Author Manuscript

OR=Odds ratio; CL= 95% confidence limit; REF=referent, AA11=amino acid 11
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460
232
600

Morgan et al.

Tezenas du Montcel et al.

Michou et al.

.19

--

.16

.11

.16

--

.13

.045

.65

--

.71

.84

CL not reported

†

--

--

1.8

2.1

--

--

2.7

2.8

S2

S3P

L

S3P

S2

ORAllelic (CL)

Tezenas du Montcel MAF (controls)

MAF= minor allele frequency; OR=odds ratio; CL=95% confidence limit

*

776

Ahmed et al (this report).

N

studies in European populations

*

8.2 (3-21)

3.3

†

7.14 (3-16)

4.9 (1.9-13)

S3P/S3P

ORGenotypic (CL)

20.5 (7-59)

†

5.9

13.74 (5.5-34)

2.6 (0.48-14)

S2/S2

22 (10-50)

†

6.6

7.4 (4.6-12)

9.3 (3.4-26)

S2/S3P

5.9 (3-12)

†

2.7

2.9 (2.2-3.9)

2.8 (2.0-4.1)

S2/L

4.4 (2.3-8.4)

†
1.9

2.1 (1.6-2.8)

2.0 (1.5-2.7)

S3P/L

Comparison of Tezenas du Montcel classification system allele frequencies and allelic and genotypic odds ratios across the present study and selected
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